Progesterone
Internal ID | ce160985-4f69-4c40-b05e-df0c91636007 |
Taxonomy | Lipids and lipid-like molecules > Steroids and steroid derivatives > Pregnane steroids > Gluco/mineralocorticoids, progestogins and derivatives |
IUPAC Name | (8S,9S,10R,13S,14S,17S)-17-acetyl-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one |
SMILES (Canonical) | CC(=O)C1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C |
SMILES (Isomeric) | CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C |
InChI | InChI=1S/C21H30O2/c1-13(22)17-6-7-18-16-5-4-14-12-15(23)8-10-20(14,2)19(16)9-11-21(17,18)3/h12,16-19H,4-11H2,1-3H3/t16-,17+,18-,19-,20-,21+/m0/s1 |
InChI Key | RJKFOVLPORLFTN-LEKSSAKUSA-N |
Popularity | 120,599 references in papers |
Molecular Formula | C21H30O2 |
Molecular Weight | 314.50 g/mol |
Exact Mass | 314.224580195 g/mol |
Topological Polar Surface Area (TPSA) | 34.10 Ų |
XlogP | 3.90 |
Atomic LogP (AlogP) | 4.72 |
H-Bond Acceptor | 2 |
H-Bond Donor | 0 |
Rotatable Bonds | 1 |
57-83-0 |
Pregn-4-ene-3,20-dione |
Agolutin |
Crinone |
4-Pregnene-3,20-dione |
Utrogestan |
Prometrium |
Syngesterone |
Luteol |
Cyclogest |
There are more than 10 synonyms. If you wish to see them all click here. |
Target | Value | Probability (raw) | Probability (%) |
---|---|---|---|
Human Intestinal Absorption | + | 1.0000 | 100.00% |
Caco-2 | + | 0.8534 | 85.34% |
Blood Brain Barrier | + | 0.8500 | 85.00% |
Human oral bioavailability | - | 0.8286 | 82.86% |
Subcellular localzation | Mitochondria | 0.6698 | 66.98% |
OATP2B1 inhibitior | - | 1.0000 | 100.00% |
OATP1B1 inhibitior | + | 0.7650 | 76.50% |
OATP1B3 inhibitior | + | 0.9819 | 98.19% |
MATE1 inhibitior | - | 0.7800 | 78.00% |
OCT2 inhibitior | + | 0.8000 | 80.00% |
BSEP inhibitior | + | 0.9001 | 90.01% |
P-glycoprotein inhibitior | + | 0.9518 | 95.18% |
P-glycoprotein substrate | - | 0.9309 | 93.09% |
CYP3A4 substrate | + | 0.7980 | 79.80% |
CYP2C9 substrate | - | 1.0000 | 100.00% |
CYP2D6 substrate | - | 0.8713 | 87.13% |
CYP3A4 inhibition | - | 0.8309 | 83.09% |
CYP2C9 inhibition | - | 0.9071 | 90.71% |
CYP2C19 inhibition | - | 0.6514 | 65.14% |
CYP2D6 inhibition | - | 0.9533 | 95.33% |
CYP1A2 inhibition | - | 0.9045 | 90.45% |
CYP2C8 inhibition | - | 0.9229 | 92.29% |
CYP inhibitory promiscuity | - | 0.8203 | 82.03% |
UGT catelyzed | - | 0.0000 | 0.00% |
Carcinogenicity (binary) | - | 0.9800 | 98.00% |
Carcinogenicity (trinary) | Warning | 0.4528 | 45.28% |
Eye corrosion | - | 0.9911 | 99.11% |
Eye irritation | - | 0.9704 | 97.04% |
Skin irritation | + | 0.6173 | 61.73% |
Skin corrosion | - | 0.9668 | 96.68% |
Ames mutagenesis | - | 0.9574 | 95.74% |
Human Ether-a-go-go-Related Gene inhibition | - | 0.4103 | 41.03% |
Micronuclear | - | 0.9200 | 92.00% |
Hepatotoxicity | + | 0.9500 | 95.00% |
skin sensitisation | + | 0.6755 | 67.55% |
Respiratory toxicity | + | 0.9667 | 96.67% |
Reproductive toxicity | + | 1.0000 | 100.00% |
Mitochondrial toxicity | + | 0.9375 | 93.75% |
Nephrotoxicity | - | 0.8418 | 84.18% |
Acute Oral Toxicity (c) | III | 0.8127 | 81.27% |
Estrogen receptor binding | + | 0.9117 | 91.17% |
Androgen receptor binding | + | 0.8747 | 87.47% |
Thyroid receptor binding | + | 0.8460 | 84.60% |
Glucocorticoid receptor binding | + | 0.9162 | 91.62% |
Aromatase binding | + | 0.7294 | 72.94% |
PPAR gamma | - | 0.6860 | 68.60% |
Honey bee toxicity | - | 0.8469 | 84.69% |
Biodegradation | - | 0.7750 | 77.50% |
Crustacea aquatic toxicity | + | 0.5200 | 52.00% |
Fish aquatic toxicity | + | 0.9910 | 99.10% |
Proven Targets:
CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
---|---|---|---|---|---|
CHEMBL2782 | P35610 | Acyl coenzyme A:cholesterol acyltransferase 1 |
17000 nM |
IC50 |
PMID: 3100794
|
CHEMBL3577 | P00352 | Aldehyde dehydrogenase 1A1 |
25118.9 nM 28183.8 nM |
Potency Potency |
via CMAUP
via CMAUP |
CHEMBL1871 | P10275 | Androgen Receptor |
37 nM 8.5 nM 37 nM 37 nM 37 nM 37 nM |
IC50 Ki IC50 IC50 IC50 IC50 |
PMID: 9784110
via Super-PRED PMID: 9464360 PMID: 8627601 PMID: 12781197 PMID: 12954062 |
CHEMBL2421 | P08185 | Corticosteroid binding globulin |
41.69 nM |
Ki |
PMID: 15139751
|
CHEMBL3397 | P11712 | Cytochrome P450 2C9 |
5500 nM |
Ki |
PMID: 14761192
|
CHEMBL340 | P08684 | Cytochrome P450 3A4 |
3981.1 nM 3981.1 nM 3981.1 nM 3981.1 nM |
Potency Potency Potency Potency |
via CMAUP
via CMAUP via CMAUP via CMAUP |
CHEMBL4879 | P12104 | Fatty acid binding protein intestinal |
20000 nM |
Ki |
PMID: 18533710
|
CHEMBL5409 | Q8TDU6 | G-protein coupled bile acid receptor 1 |
2770 nM |
EC50 |
PMID: 18307294
|
CHEMBL2034 | P04150 | Glucocorticoid receptor |
330 nM 30.5 nM |
IC50 Ki |
via CMAUP
via Super-PRED |
CHEMBL4261 | Q16665 | Hypoxia-inducible factor 1 alpha |
12589.3 nM 12589.3 nM |
Potency Potency |
via CMAUP
via CMAUP |
CHEMBL1293226 | B2RXH2 | Lysine-specific demethylase 4D-like |
39810.7 nM |
Potency |
via CMAUP
|
CHEMBL4040 | P28482 | MAP kinase ERK2 |
39810.7 nM 14125.4 nM |
Potency Potency |
via CMAUP
via CMAUP |
CHEMBL1293224 | P10636 | Microtubule-associated protein tau |
39810.7 nM |
Potency |
via CMAUP
|
CHEMBL1994 | P08235 | Mineralocorticoid receptor |
0.39 nM 14 nM 14 nM 14 nM 14 nM |
Kd IC50 IC50 IC50 IC50 |
via Super-PRED
PMID: 9784110 PMID: 12781197 PMID: 9464360 PMID: 12954062 |
CHEMBL5162 | Q6W5P4 | Neuropeptide S receptor |
10000 nM |
Potency |
via CMAUP
|
CHEMBL4302 | P08183 | P-glycoprotein 1 |
48977.88 nM 192200 nM 88100 nM 96200 nM 47863.01 nM 47863.01 nM |
IC50 IC50 IC50 IC50 IC50 IC50 |
PMID: 17890094
PMID: 11716514 PMID: 11716514 PMID: 11716514 PMID: 18678495 PMID: 17890094 |
CHEMBL1293235 | P02545 | Prelamin-A/C |
35481.3 nM 35481.3 nM 10000 nM 6309.6 nM |
Potency Potency Potency Potency |
via CMAUP
via CMAUP via CMAUP via CMAUP |
CHEMBL208 | P06401 | Progesterone receptor |
0.1 nM 5 nM 17 nM 3.5 nM 0.2 nM |
EC50 IC50 IC50 IC50 IC50 |
via Super-PRED
PMID: 8523399 PMID: 8523400 PMID: 11859003 PMID: 24900290 |
CHEMBL287 | Q99720 | Sigma opioid receptor |
3055 nM |
IC50 |
via CMAUP
|
CHEMBL5685 | O15245 | Solute carrier family 22 member 1 |
3050 nM |
IC50 |
PMID: 12110607
|
CHEMBL1743122 | O15244 | Solute carrier family 22 member 2 |
26700 nM |
IC50 |
PMID: 12110607
|
CHEMBL2073673 | O75751 | Solute carrier family 22 member 3 |
4280 nM |
IC50 |
PMID: 12110607
|
CHEMBL1293232 | Q16637 | Survival motor neuron protein |
15848.9 nM 14125.4 nM |
Potency Potency |
via CMAUP
via CMAUP |
CHEMBL3305 | P04278 | Testis-specific androgen-binding protein |
114.82 nM |
Kd |
via Super-PRED
|
CHEMBL1293256 | P40225 | Thrombopoietin |
10000 nM 10000 nM |
Potency Potency |
via CMAUP
via CMAUP |
CHEMBL1963 | P16473 | Thyroid stimulating hormone receptor |
10000 nM 25118.9 nM 25118.9 nM 10000 nM |
Potency Potency Potency Potency |
via CMAUP
via CMAUP via CMAUP via CMAUP |
Predicted Targets (via Super-PRED):
CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
---|---|---|---|---|
CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 96.70% | 96.09% |
CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 93.80% | 91.11% |
CHEMBL4224 | P49759 | Dual specificty protein kinase CLK1 | 92.38% | 85.30% |
CHEMBL3746 | P80365 | 11-beta-hydroxysteroid dehydrogenase 2 | 90.04% | 94.78% |
CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 88.45% | 95.56% |
CHEMBL340 | P08684 | Cytochrome P450 3A4 | 86.92% | 91.19% |
CHEMBL253 | P34972 | Cannabinoid CB2 receptor | 85.63% | 97.25% |
CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 84.48% | 94.45% |
CHEMBL3351 | Q13085 | Acetyl-CoA carboxylase 1 | 82.78% | 93.04% |
CHEMBL1940 | Q13936 | Voltage-gated L-type calcium channel alpha-1C subunit | 82.75% | 86.00% |
CHEMBL2581 | P07339 | Cathepsin D | 81.86% | 98.95% |
CHEMBL1806 | P11388 | DNA topoisomerase II alpha | 80.29% | 89.00% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.